Christopher Vann
Fortune : 359 435 $ au 31/05/2026
Fortune : 359 435 $ au 31/05/2026
Christopher Vann currently works at Alliance for Regenerative Medicine, as Treasurer & Director from 2023 and Autolus Therapeutics Plc, as Chief Operating Officer & Senior Vice President from 2016.
Mr. Vann also formerly worked at Roche Holding AG, as Commercial Director from 1994 to 2016.
Mr. Vann received his undergraduate degree from School of Pharmacy.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AUTOLUS THERAPEUTICS PLC 0,12 % | 18/03/2026 | 192 211 ( 0,12 % ) | 359 435 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Directeur des opérations | 01/10/2016 |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Directeur/Membre du Conseil | 01/01/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/09/2016 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Roche Holding AG
Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
School of Pharmacy
School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Autolus Therapeutics Plc
Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national